DarioHealth posted $5.3 million in Q3 revenue, up 6% year-over-year, while cutting operating expenses by 10% and securing a major New Jersey health plan contract covering 1.5 million lives.
Q3 2026 revenue of $5.3 million grew 6% year-over-year and 3% sequentially, operating loss fell 15% and operating expenses fell 10% year-over-year, showing the cost-reduction path is working. The company also signed one of New Jersey's largest health plans with 1.5 million covered lives and holds $31.2 million in cash and short-term deposits as of September 30, 2026. Against this, B2B and B2B2C revenue declined on non-renewal of Twill's legacy contracts and gross margin slipped to 59% from 60%, so the improvement is gradual rather than a step change.
DarioHealth reported third-quarter 2026 revenue of $5.3 million, marking a 6% year-over-year increase. The company successfully reduced operating expenses by 10% and narrowed its operating loss by 15% compared to the same period last year, supported by a $31.2 million cash position as of September 30, 2026.
Cash, cash equivalents and short-term deposits totaled $31.2 million as of September 30, 2026.
Total revenue grew 6% year-over-year to $5.3 million and direct-to-consumer sales rose about 48%, but B2B and B2B2C revenue declined because several of Twill's legacy contracts were not renewed. Operating expenses fell 10% and the operating loss narrowed 15% year-over-year.